This Conference brings together representatives from federal agencies, industry, patient-advocacy groups, and academics to explore government initiatives and priorities concerning a range of topics.
Reed Smith counsel Sarah Thompson-Schick will be speaking on a panel titled, "Translating PROs and Diverse Clinical Trial Data into Credible Insights."